​

VistaGen Therapeutics Ownership | Who Owns VistaGen Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

VistaGen Therapeutics Ownership Summary

VistaGen Therapeutics is owned by 48.52% institutional investors, 0.34% insiders, and 51.14% retail investors. Tcg crossover management is the largest institutional shareholder, holding 8.38% of VTGN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.43% of its assets in VistaGen Therapeutics shares.

VTGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVistaGen Therapeutics48.52%0.34%51.14%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tcg crossover management2.68M8.38%$5.35M
Stempoint capital lp2.41M7.56%$4.12M
Nantahala capital management1.98M6.20%$3.96M
Ikarian capital601.70K1.88%$1.20M
Sphera funds management447.94K1.40%$895.88K
Adar1 capital management420.76K1.32%$841.53K
Blackrock funding, inc. /de416.89K1.31%$833.78K
Almitas capital261.40K0.82%$522.80K
Advisorshares investments203.11K0.64%$406.23K
Boothbay fund management177.86K0.56%$355.72K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stempoint capital lp2.41M1.32%$4.12M
Tcg crossover management2.68M0.61%$5.35M
Ikarian capital601.70K0.23%$1.20M
Bml capital management150.00K0.23%$300.00K
Sphera funds management447.94K0.21%$895.88K
Nantahala capital management1.98M0.15%$3.96M
Almitas capital261.40K0.13%$522.80K
Adar1 capital management420.76K0.13%$841.53K
Advisorshares investments203.11K0.07%$406.23K
Boothbay fund management177.86K0.01%$355.72K

Top Buyers

HolderShares% AssetsChange
Stempoint capital lp2.41M1.32%46.70K
Advisorshares investments203.11K0.07%44.00K
Marshall wace, llp34.64K0.00%34.64K
Truvestments capital7.16K0.00%7.16K
Almitas capital261.40K0.13%6.74K

Top Sellers

HolderShares% AssetsChange
Sphera funds management447.94K0.21%-342.61K
Goldman sachs group---194.53K
Squarepoint ops---107.74K
Landscape capital management---41.80K
Millennium management---38.73K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp34.64K0.00%34.64K$69.28K
Truvestments capital7.16K0.00%7.16K$14.31K
Raymond james financial6.41K-6.41K$12.82K

Sold Out

HolderChange
Sjs investment consulting-100.00
Tower research capital llc (trc)-223.00
Bfsg-1.00K
Caption management-4.46K
Cubist systematic strategies-10.09K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025536.00%15,493,303-1.24%481.86%2578.57%10-52.38%
Mar 31, 202551-16.39%15,943,0802.72%512.03%15-54.55%2066.67%
Dec 31, 20246115.09%15,520,6051.70%502.04%3394.12%12-7.69%
Sep 30, 20245312.77%15,260,546-6.59%491.75%1713.33%13-
Jun 30, 20241-2,676,580-1316.67%----

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.28M4.43%-
Vanguard Total Stock Mkt Idx Inv1.16M3.90%-25.43K
Vanguard Institutional Extnd Mkt Idx Tr337.37K1.13%-208.17K
AdvisorShares Psychedelics ETF218.01K0.73%-
Fidelity Extended Market Index129.71K0.43%-339.00
BlackRock Extended Equity Market K61.89K0.23%-26.00
iShares Micro-Cap ETF65.01K0.22%-
A4Investments SICAV SIF ACCI IlanaA2EURH60.00K0.22%-
Extended Equity Market Fund K60.04K0.21%-1.20K
Fidelity Total Market Index47.48K0.16%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 07, 2023COMMODORE CAPITAL LP-Buy$17.96M
Aug 18, 2022GIN JERRY B Buy$17.87K
Aug 17, 2022Adler Reid G. CHIEF LEGAL OFFICERBuy$50.91K
Aug 17, 2022Singh Shawn CHIEF EXECUTIVE OFFICERBuy$103.20K
Jul 12, 2022Shah Nimish P Sell$53.40K

Insider Transactions Trends

DateBuySell
2025 Q2--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

VTGN Ownership FAQ

Who Owns VistaGen Therapeutics?

VistaGen Therapeutics shareholders are primarily institutional investors at 48.52%, followed by 0.34% insiders and 51.14% retail investors. The average institutional ownership in VistaGen Therapeutics's industry, Biotech Stocks , is 304.14%, which VistaGen Therapeutics falls below.

Who owns the most shares of VistaGen Therapeutics?

VistaGen Therapeutics’s largest shareholders are Tcg crossover management (2.68M shares, 8.38%), Stempoint capital lp (2.41M shares, 7.56%), and Nantahala capital management (1.98M shares, 6.20%). Together, they hold 22.14% of VistaGen Therapeutics’s total shares outstanding.

Does Blackrock own VistaGen Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VistaGen Therapeutics.

Who is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested?

Stempoint capital lp is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.32% of its assets in 2.41M VistaGen Therapeutics shares, valued at 4.12M$.

Who is the top mutual fund holder of VistaGen Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of VistaGen Therapeutics shares, with 4.43% of its total shares outstanding invested in 1.28M VistaGen Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools